EA202193221A1 - METHOD FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE USING COMBINED THERAPY WITH ANTIBODIES TO IL-23 AND TNF-ALFA - Google Patents

METHOD FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE USING COMBINED THERAPY WITH ANTIBODIES TO IL-23 AND TNF-ALFA

Info

Publication number
EA202193221A1
EA202193221A1 EA202193221A EA202193221A EA202193221A1 EA 202193221 A1 EA202193221 A1 EA 202193221A1 EA 202193221 A EA202193221 A EA 202193221A EA 202193221 A EA202193221 A EA 202193221A EA 202193221 A1 EA202193221 A1 EA 202193221A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tnf
alfa
antibodies
treatment
combined therapy
Prior art date
Application number
EA202193221A
Other languages
Russian (ru)
Inventor
Мэттью Джерминаро
Кристофер О'Брайен
Жаклин Перригу
Original Assignee
Янссен Байотек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Байотек, Инк. filed Critical Янссен Байотек, Инк.
Priority claimed from PCT/IB2020/054859 external-priority patent/WO2020234834A1/en
Publication of EA202193221A1 publication Critical patent/EA202193221A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ лечения воспалительных заболеваний кишечника, таких как язвенный колит, включает в себя введение ингибитора ИЛ-23, такого как антитело к ИЛ-23р19 (например, гуселкумаб), и ингибитора ФНО-, такого как антитело к ФНО- (например, голимумаб).A method of treating inflammatory bowel disease such as ulcerative colitis comprises administering an IL-23 inhibitor such as an anti-IL-23p19 antibody (eg, guselcumab) and a TNF-α inhibitor such as an anti-TNF-α antibody (eg, golimumab).

EA202193221A 2019-09-05 2020-05-21 METHOD FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE USING COMBINED THERAPY WITH ANTIBODIES TO IL-23 AND TNF-ALFA EA202193221A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962896205P 2019-09-05 2019-09-05
PCT/IB2020/054859 WO2020234834A1 (en) 2019-05-23 2020-05-21 Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Publications (1)

Publication Number Publication Date
EA202193221A1 true EA202193221A1 (en) 2022-03-10

Family

ID=81077494

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202193221A EA202193221A1 (en) 2019-09-05 2020-05-21 METHOD FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE USING COMBINED THERAPY WITH ANTIBODIES TO IL-23 AND TNF-ALFA

Country Status (1)

Country Link
EA (1) EA202193221A1 (en)

Similar Documents

Publication Publication Date Title
MX2021014302A (en) Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha.
EA202092605A1 (en) ANTIBODIES TO IL-11RA
EA201491011A1 (en) METHODS OF TREATMENT BY MEANS OF THE GAMMA INTERFERON INHIBITOR
CL2020003223A1 (en) Il-11 antibodies
EA201991556A1 (en) PHOSPHODIESTHESIS INHIBITORS AND METHODS FOR TREATING MICROBIAL INFECTION
EA201790530A1 (en) AGENTS CONNECTING CD123 AND TYPES OF THEIR APPLICATION
EA201790398A1 (en) METHODS OF TREATING LIVER DISEASES
MX2022014430A (en) Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha.
PH12019500946A1 (en) Neutralizing anti-tl1a monoclonal antibodies
EA201890519A1 (en) INHIBITING ANTIBODIES AGAINST PCSK9 FOR THE TREATMENT OF PATIENTS WITH HYPERLIPIDEMIA EXPOSING TO LIPOPROTEIN SCARVA
EA202091810A1 (en) ANTIBODIES TO B7-H4 AND METHODS OF THEIR APPLICATION
MX2021012407A (en) Combination therapy with an anti bcma antibody and a gamma secretase inhibitor.
EA202091989A1 (en) METHODS FOR TREATMENT OF ULCER
EA201891388A1 (en) PLASMA KALLIKREIN INHIBITORS AND THEIR APPLICATION FOR THE TREATMENT OF THE EXPOSURE OF HEREDITARY ANGIONEUROTIC DOMESTIC
MA35173B1 (en) Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer
JOP20210166A1 (en) Treatment of medication overuse headache using anti-cgrp or anti-cgrp-r antibodies
EA202191666A1 (en) ANTIBODIES TO IL-27 AND THEIR USE
WO2016029079A3 (en) Monoclonal antibodies for treatment of microbial infections
EA201990613A1 (en) ANTIBODIES AGAINST GREEMLIN-1 (GREM1) AND METHODS OF THEIR APPLICATION FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
EA201992431A1 (en) COMBINED CANCER IMMUNOTHERAPY USING PENTA-ASA-MACROCYCLIC RING COMPLEX
EA202193221A1 (en) METHOD FOR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE USING COMBINED THERAPY WITH ANTIBODIES TO IL-23 AND TNF-ALFA
BR112023024064A2 (en) METHOD OF TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH A COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF-ALPHA
EA202190504A1 (en) METHODS FOR TREATMENT OF PSORIASIS
EA202190197A1 (en) TREATMENT OF ULCER WITH BRAZIKUMAB
MX2018004663A (en) Two-dimensional imaging with multi-stage processing.